EUVIMEDEUVIMED entdecken
Leserbrief

Reply to “Distinguishing the Fibrosis-3 Index From FIB-4 Without Age: Clarification and an Invitation for External Validation”

Jeevan Nammi, Fernando Bril

Clinical Gastroenterology and Hepatology · 2026-11

DOI: 10.1016/j.cgh.2026.10.024 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Clinical Gastroenterology and Hepatology, 2026-11. Verfasst von Jeevan Nammi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA; UAB Comprehensive Diabetes Center, University of Alabama at Birmingham, Birmingham, A…

Zitieren

APA

Nammi, J., & Bril, F. (2026). Reply to “Distinguishing the Fibrosis-3 Index From FIB-4 Without Age: Clarification and an Invitation for External Validation”. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2026.10.024

Vancouver

Nammi J, Bril F. Reply to “Distinguishing the Fibrosis-3 Index From FIB-4 Without Age: Clarification and an Invitation for External Validation”. Clinical Gastroenterology and Hepatology. 2026. doi:10.1016/j.cgh.2026.10.024

BibTeX
@article{Nammi2026,
  author = {Nammi, Jeevan and Bril, Fernando},
  title = {Reply to “Distinguishing the Fibrosis-3 Index From FIB-4 Without Age: Clarification and an Invitation for External Validation”},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2026},
  doi = {10.1016/j.cgh.2026.10.024}
}
Kostenlos starten →